Seasonal variation in expression of markers in the vitamin D pathway in prostate tissue

Cancer Causes and Control

Volumn 23, Issue 8, 2012, Pages 1359-1366

  Epstein, Mara M ^a,b   Andrén, Ove ^c   Kasperzyk, Julie L ^a,b   Shui, Irene M ^a   Penney, Kathryn L ^a,b   Fall, Katja ^c   Rider, Jennifer R ^a,b   Stampfer, Meir J ^a,b   Andersson, Swen Olof ^c   Giovannucci, Edward ^a   Mucci, Lorelei A ^a,b,d  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF ICELAND   (Iceland)

Author keywords

Biomarkers; Gene expression; Prostate cancer; Seasonality; Vitamin D; Vitamin D receptor

Indexed keywords

25 HYDROXYVITAMIN D; CHOLESTANETRIOL 26 MONOOXYGENASE; CYTOCHROME P450; CYTOCHROME P450 24A1; CYTOCHROME P450 27B1; MESSENGER RNA; RETINOID X RECEPTOR ALPHA; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D BINDING PROTEIN; VITAMIN D RECEPTOR;

AGED; ARTICLE; CONTROLLED STUDY; CYP24A1 GENE; CYP27A1 GENE; CYP27B1 GENE; ETHNIC GROUP; GENE; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC VARIABILITY; GLEASON SCORE; GROUP SPECIFIC COMPONENT GENE; HUMAN; HUMAN TISSUE; LETHALITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE TUMOR; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SEASONAL VARIATION; SWEDISH; TISSUE LEVEL; VITAMIN D METABOLISM; VITAMIN D RECEPTOR GENE;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; CHOLESTANETRIOL 26-MONOOXYGENASE; COHORT STUDIES; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RECEPTORS, CALCITRIOL; RETINOID X RECEPTOR ALPHA; RNA, MESSENGER; SEASONS; STEROID HYDROXYLASES; TUMOR MARKERS, BIOLOGICAL; VITAMIN D; VITAMIN D-BINDING PROTEIN;

EID: 84864872046     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-0016-9     Document Type: Article

References (24)

1. Ingles SA, Ross RK, Yu MC et al (1997) Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst 89(2):166-170
2. Holt SK, Kwon EM, Koopmeiners JS et al (2010) Vitamin D pathway gene variants and prostate cancer prognosis. Prostate 70(13):1448-1460
3. Chen L, Davey Smith G, Evans DM et al. (2009) Genetic variants in the vitamin d receptor are associated with advanced prostate cancer at diagnosis: findings from the prostate testing for cancer and treatment study and a systematic review. Cancer Epidemiol Biomarkers Prev 18(11):2874-2881
4. Shui IM, Mucci LA, Kraft P et al (2012) Vitamin D related genetic variation, plasma vitamin D, and risk of lethal prostate cancer. J Natl Cancer Inst 104(9):690-699
5. Schwartz GG, Whitlatch LW, Chen TC et al (1998) Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. Cancer Epidemiol Biomarkers Prev 7(5):391-395
6. Deeb KK, Trump DL, Johnson CS (2007) Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 7(9):684-700
7. Webb AR, Kline L, Holick MF (1988) Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 67(2):373-378
8. Kimlin MG (2008) Geographic location and vitamin D synthesis. Mol Aspects Med 29(6):453-461
9. Savolainen K, Maenpaa PH, Alhava EM et al (1980) A seasonal difference in serum 25-hydroxyvitamin D3 in a Finnish population. Med Biol 58(1):49-52
10. McCullough ML, Weinstein SJ, Freedman DM et al (2010) Correlates of circulating 25-hydroxyvitamin D: cohort consortium vitamin D pooling project of rarer cancers. Am J Epidemiol 172(1):21-35
11. Pedersen JI (2008) Vitamin D requirement and setting recommendation levels-current Nordic view. Nutr Rev 66(10 Suppl 2):S165-S169
12. Hendrickson WK, Flavin R, Kasperzyk JL et al (2011) Vitamin d receptor protein expression in tumor tissue and prostate cancer progression. J Clin Oncol 29(17):2378-2385
13. Setlur SR, Mertz KD, Hoshida Y et al (2008) Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer. J Natl Cancer Inst 100(11):815-825
14. Sboner A, Demichelis F, Calza S et al (2010) Molecular sampling of prostate cancer: a dilemma for predicting disease progression. BMC Med Genomics 3:8
15. Hennekens CH, Buring JE, Manson JE et al (1996) Lack of effect of long-term supplementation with beta carotene on the incidenceof malignant neoplasms and cardiovascular disease. N Engl J Med 334(18):1145-1149
16. Final report on the aspirin component of the ongoing Physicians' Health Study (1989) Steering Committee of the Physicians' Health Study Research Group. N Engl J Med 21(3):129-135
17. Giovannucci E, Ascherio A, Rimm EB et al (1995) Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 87(23):1767-1776
18. Fan JB, Yeakley JM, Bibikova M et al (2004) A versatile assay for high-throughput gene expression profiling on universal array matrices. Genome Res 14(5):878-885
19. Bibikova M, Yeakley JM, Chudin E et al (2004) Gene expression profiles in formalin-fixed, paraffin-embedded tissues obtained with a novel assay for microarray analysis. Clin Chem 50(12):2384-2386
20. US Environmental Protection Agency (2010) Monthly average UV index. US Environmental Protection Agency [cited 2011 September 20]; Available from: http://www.epa.gov/sunwise/uvimonth.html
21. The Swedish Radiation Safety Authority (SSM) (2010) Report from the SSM's Scientific Council on Ultraviolet Radiation 2010 [2011:14 Rapport från SSM:s vetenskapliga råd om ultraviolett strålning 2010]. Stockholm, Sweden
22. Giovannucci E (2005) The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 16(2):83-95
23. Holmberg L, Adolfsson J, Mucci L et al (2009) Season of diagnosis and prognosis in breast and prostate cancer. Cancer Causes Control 20(5):663-670
24. Stark JR, Perner S, Stampfer MJ et al (2009) Gleason score and lethal prostate cancer: does 3 ? 4 = 4 ? 3? J Clin Oncol 27(21):3459-3464